key: cord-0990765-rjnafh65 authors: ALIMOHAMADI, YOUSEF; SEPANDI, MOJTABA; TAGHDIR, MARYAM; HOSAMIRUDSARI, HADISEH title: Determine the most common clinical symptoms in COVID-19 patients: a systematic review and meta-analysis date: 2020-10-06 journal: J Prev Med Hyg DOI: 10.15167/2421-4248/jpmh2020.61.3.1530 sha: 46c0462b2607dd4afcb727bf0a5d9edb78577e98 doc_id: 990765 cord_uid: rjnafh65 INTRODUCTION: COVID-19 is an emerging infectious disease. The study about features of this infection could be very helpful in better knowledge about this infectious disease. The current systematic review and meta-analysis were aimed to estimate the prevalence of clinical symptoms of COVID-19 in a systematic review and meta-analysis. METHODS: A systematic review using Medline/PubMed, Scopus, and Google scholar has been conducted. In the current systematic review and meta-analysis, the articles published in the period January 1, 2020, to April 2, 2020, written in English and reporting clinical symptoms of COVID-19 was reviewed. To assess, the presence of heterogeneity, the Cochran’s Q statistic, the I(2) index, and the tau-squared test were used. Because of significant heterogeneity between the studies the random-effects model with 95% CI was used to calculate the pooled estimation of each symptom prevalence. RESULTS: The most common symptoms in COVID-19 patients include: Fever 81.2% (95% CI: 77.9-84.4); Cough: 58.5% (95% CI: 54.2-62.8); Fatigue 38.5% (95% CI: 30.6-45.3); Dyspnea: 26.1% (95% CI: 20.4-31.8); and the Sputum: 25.8% (95% CI: 21.1-30.4). Based on the meta-regression results, the sample size used in different studies did not have a significant effect on the final estimate value (P > 0.05). CONCLUSIONS: Considering the main symptoms of COVID-19 such as Fever, Cough, Fatigue, and Dyspnea can have a key role in early detection of this disease and prevent the transmission of the disease to other people. The World Health Organization (WHO) described Coronavirus 2019 (COVID-19) as a public health emergency. The international concern of COVID-19 is more in comparison to Severe Acute Respiratory Syndrome (SARS), which previously was pandemic in 2003 [1] . Coronaviruses are important pathogens that can affect the lower respiratory tract in humans and can cause diseases ranging from a simple cold to severe infection with up to 50% lethality [2] . The COVID-19 is a highly contagious infectious disease and one infected person can infect an average of three other people [3] which is higher than that for SARS (1.7-1.9) and MERS (< 1), suggesting that SARS-CoV-2 has a greater potential for being outbreak. Evidence suggests that there are many similarities between COVID-19 and SARS. About 79.5% of the similarities in the genome sequence of these two viruses have been reported [4] . can spread in the community more easily than MERS and SARS because of the less severe clinical picture of it [5] . Although the disease is mild in most people, in some patients, especially those with other underlying diseases, there may be a respiratory failure, arrhythmias, shock, Kidney failure, cardiovascular damage, or liver failure [6, 7] . Currently, there is no effective antiviral treatment for the disease and only supportive care may be helpful [7] The case fatality rate (CFR) of COVID-19 was reported to be 3.8% but it can differ in patients who have comorbidities [8] . The CFR of COVID-19 is lower than that of SARS and that of MERS [5] . The most common symptoms are fever, cough, and myalgia or fatigue [9] . Although the clinical symptoms of the disease are nonspecific, understanding the symptoms is essential. Patient with fever and upper respiratory tract symptoms with lymphopenia or leukopenia should be considered as suspected [9] Patients may present with diarrhea a few days before the fever. A slight number of patients may report a headache [10] . Diarrhea is more common in SARS [5] . Combining the results of studies that have focused on the prevalence of COVID-19 related symptoms could be helpful in the best identification and diagnosis of infection. Because of the importance of symptoms in the identification of COVID-19 infection the current study was aimed to estimate the prevalence of Clinical Symptoms of COVID-19 in a systematic review and meta-analysis. According to the results of the analysis, the most common symptoms in patients with coronavirus include: • Fever 81.2% (95% CI: 77. 9 Figure 2 . Figure 2 presents the pooled estimation of some symptoms among COVID-19 patients. Based on the meta-regression results, the sample size used in different studies did not have a significant effect on the final estimate value (P > 0.05). The distribution of the estimated prevalence of different symptoms according to sample sizes as shown in Figure 3 . The diagrams below show the percentage distribution of symptom estimation based on the volume of different samples. Based on these charts, the estimated amount of chest pain, cough, dyspnea, hemoptysis, and fever with decreasing sample size showed a decreasing trend, while other symptoms showed an increasing trend with increasing sample size. Tab. I. Characteristics of the included studies on effective factors on mortality COVID-19, 2020. The COVID-19 is a new highly contagious infection that threatens people of all countries [64] . The clinical presentation of COVID-19 is wide, from asymptomatic infection to severe fatal diseases [14] Considering the shortage of diagnostic kits around the world this systematic review seems necessary, to find the clinical presentation of COVID-19 and using them in early diagnosis of this infection [13] . Unfortunately, there is no treatment for this virus, and patients' treatment is just focused on supportive care. On the other hand, the limited number of critical care centers and mechanical ventilation in the world culminates in high concern for the health care system [7] . To date, over 1,607,912 cases have been reported worldwide and from different countries [65] . To deal with such an emerging infectious disease, there an urgent need to identify and determine factors associated with the evolution of the disease and its outcomes. In this Systematic Review and Meta-Analysis study, we reported the clinical symptoms of COVID-19. Although the 2019-nCoV sequence is not the same as the other two viruses (SARS-CoV and MERS-CoV) that were pandemic in 2003 and 2012, respectively, they are somewhat similar in pathogenesis [66, 67] . Cytokines may play a role in human coronavirus infection. Indirect evidence suggests that in the second phase of 2019-nCoV infection: high fever, pneumonia, and hypoxemia occur despite a significant reduction in viral load [68] . In this systematic review and meta-analysis study, the clinical symptoms of COVID-19 were examined to provide a better understanding of the disease. The most common symptoms were fever and, cough, and fatigue that was consistent with the general symptoms of a viral infection and pneumonia. Similar to previous studies [25, 62] , the present study showed that fever in 81.2% of cases, cough in 58.5% of cases, and fatigue in 38.5% of cases. Fever is the most common symptom in patients with COVID-19, but not all patients had fever [13, 69] . The fever is an alarming sign of the disease, vomiting, and fever (above 39 degrees) are usually associated with more severe illness and more length of stay in the hospital. Fever is less common in COVID-19 than in SARS and MERS [34, 70] . Therefore, more attention should be paid to COVID-19 patients who do not have fever as a source clue of infection, and if the surveillance system relies only on fever in patients, then some patients will be missed [71] . Diarrhea, myalgia, hemoptysis, and sore throats were less common symptoms in this review, these results were similar to those obtained for other viruses, such as SARS and MERS [26] . This may indicate that COVID-19 can also be classified as a similar infection to SARS and MERS infection, which targets the cells of the lower respiratory tract system. Although nasopharynx is theoretically the first organ infected with the COVID-19, a recent study [13] showed that infected individuals rarely show present upper respiratory symptoms at the onset of the infection. This suggests that the virus mostly targets the cells of the lower respiratory tract cells [72] . Research and clinical findings suggest that SARS-CoV-2 may be colonized in the nasopharynx but the immune system cannot identify COVID-19 in the early stages. Therefore, the virus can be removed from the body with its through natural reactions, including sneezing and runny nose. This demonstrates the importance of accurately identifying COVID-19 symptoms at admission. Especially considering that studies have suggested the possibility of transmission of the disease by a healthy carrier [73] . This may be one of the reasons why COVID-19 is more contagious than SARS. On the other hand, the lower incidence of early respiratory symptoms may be due to the presence of a pathogenic latency of SARS-CoV-2. Although gastrointestinal symptoms, especially diarrhea, were rare in the current study, the results of a study have shown that the SARS-CoV-2 virus can be isolated from the fecal samples of patients with gastrointestinal symptoms [74] . In another study, the SARS-CoV-2 virus has been isolated in a rectal swab of patients whose RT-PCR test results were negative with a throat swab sample [44] . Therefore, simultaneously sampling from throat and rectal may be useful, especially in patients with gastrointestinal symptoms. This review has some limitations which should be considered when interpreting the results. Most of the available studies for inclusion are from China. However the present study was done without any language restrictions and based on a comprehensive search strategy, only English electronic databases were searched; thus, it is likely that some related non-English papers have been missed. identifying COVID-19 symptoms at admission. Especially considering that studies have suggested the possibility of transmission of the disease by a healthy carrier [74] . This may be one of the reasons why COVID-19 is more contagious than SARS. On the other hand, the lower incidence of early respiratory symptoms may be due to the presence of a pathogenic latency of SARS-CoV-2. Although gastrointestinal symptoms, especially diarrhea, were rare in the current study, the results of a study have shown that the SARS-CoV-2 virus can be isolated from the fecal samples of patients with gastrointestinal symptoms [75] . In another study, the SARS-CoV-2 virus has been isolated in a rectal swab of patients whose RT-PCR test results were negative with a throat swab sample [44] . Therefore, simultaneously sampling from throat and rectal may be useful, especially in patients with gastrointestinal symptoms. This review has some limitations which should be considered when interpreting the results. Most of the available studies for inclusion are from China. However the present study was done without any language restrictions and based on a comprehensive search strategy, only English electronic databases were searched; thus, it is likely that some related non-English papers have been missed. Due to the rapid spreading of this infection, the lack of diagnostic tools, and limited intensive care units in the world, the use of other factors such as the clinical features of COVID19 can serve to give early warning for the appropriate interventions and decrease the number of death of COVID-19. So considering the main symptoms of COVID-19 such as Fever, cough Fatigue and Dyspnea can have a key role in early detection of this disease. Revisiting the one health approach in the context of COVID-19: a look into the ecology of this emerging disease Identification of a novel coronavirus in patients with severe acute respiratory syndrome The estimate of the basic reproduction number for novel coronavirus disease (COV-ID-19): a systematic review and meta-analysis Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study COVID-19, SARS and MERS: are they closely related? Clinical Microbiology and Infection How will country-based mitigation measures influence the course of the COVID-19 epidemic? The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreakan update on the status Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19) Coronavirus disease 2019 (COVID-19): a perspective from China Clinical characteristics of 2019 novel coronavirus infection in China Case series studies quality appraisal checklist Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study CT imaging features of 2019 novel coronavirus (2019-nCoV) Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia. Zhonghua jie he he hu xi za zhi = Zhonghua Jiehe he Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China The Epidemiological and Clinical Characteristics of 2019 Novel Coronavirus Infection in Changsha, China (2/10/2020). Available at Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing. Zhonghua Jie He He Hu Xi Za Zhi Analysis of CT features of 15 children with 2019 novel coronavirus infection Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Chest CT findings in patients with coronavirus disease 2019 and its relationship with clinical features Clinical and Laboratory Profiles of 75 Hospitalized Patients with Novel Coronavirus Disease Clinical characteristics and durations of hospitalized patients with COV-ID-19 in Beijing: a retrospective cohort study Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COV-ID-19): A multi-center study in Wenzhou city Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan Clinical Characteristics of Coronavirus Disease Clinical characteristics of imported cases of COVID-19 in Jiangsu province: a multicenter descriptive study Clinical characteristics of SARS-CoV-2 pneumonia compared to controls in Chinese Han population Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Clinical Features and Chest CT Manifestations of Coronavirus Disease Clinical features and outcomes of 2019 novel coronavirus-infected patients with cardiac injury Clinical features and progression of acute respiratory distress syndrome in coronavirus disease 2019 Clinical findings in critical ill patients infected with SARS-Cov-2 in Guangdong Province, China: a multi-center, retrospective, observational study Clinical findings in critical ill patients infected with SARS-Cov-2 in Guangdong Province, China: a multi-center, retrospective, observational study Early prediction of disease progression in 2019 novel coronavirus pneumonia patients outside Wuhan with CT and clinical characteristics Epidemiologic and clinical characteristics of 91 hospitalized patients with COVID-19 in Zhejiang, China: a retrospective, multi-centre case series Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore Epidemiological and clinical characteristics of COVID-19 in Shenzhen, the largest migrant city of China Epidemiological and clinical characteristics of COV-ID-19 in adolescents and young adults Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China. Medrxiv Epidemiological, clinical characteristics and outcome of medical staff infected with COV-ID-19 in Wuhan, China: A retrospective case series analysis Association between Clinical, Laboratory and CT Characteristics and RT-PCR Results in the Follow-up of COVID-19 patients Radiological findings from 81 patients with COV-ID-19 pneumonia in Wuhan, China: a descriptive study Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study Retrospective analysis of clinical features in 101 death cases with COVID-19 Risk factors associated with clinical outcomes in 323 COVID-19 hospitalized patients in Wuhan, China The characteristics and clinical value of chest CT images of novel coronavirus pneumonia Caution: clinical characteristics of COVID-19 patients are changing at admission. Available at SSRN 3546044 Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures Initial clinical features of suspected coronavirus disease 2019 in two emergency departments outside of Hubei Clinical characteristics of hospitalized patients with SARS-CoV-2 and hepatitis B virus co-infection. Virol Sin Clinical characteristics of coronavirus disease 2019 in China Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2 A new coronavirus associated with human respiratory disease in China World meters Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study Middle East respiratory syndrome World Health Organization, Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission Presumed asymptomatic carrier transmission of COVID-19 The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes We thank all authors involved in this manuscript. Funding sources: this research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The authors declare no conflict of interest. YA and MS formulated the research questions, designed the study, developed the preliminary search strategy, conducted the quality assessment, methodology, formal analysis, prepare drafts of the manuscript, review and editing, MT and HH refined the search strategy by conducting iterative database queries and incorporating new search terms, searched and collected the articles, re-viewed the manuscript content. Data extraction and prepare drafts of the manuscript. All authors critically reviewed the manuscript content. All authors have read and approved the final version of the manuscript.